Cullinan Oncology

-$0.16 (-1.33%) As of 1:36 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CGEM and other ETFs, options, and stocks.

About CGEM

Cullinan Oncology, Inc. is a biopharmaceutical company engaged in developing oncology and immuno-oncology therapies. The company was founded by Patrick R.

CEO
Nadim Ahmed
Employees
31
Headquarters
Cambridge, Massachusetts
Founded
2016

CGEM Key Statistics

Market cap
530.40M
Price-Earnings ratio
—
Dividend yield
—
Average volume
2.06M
High today
$12.21
Low today
$11.57
Open price
$11.60
Volume
5.88K
52 Week high
$37.66
52 Week low
$7.30

CGEM Earnings

-$0.74
-$0.49
-$0.25
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
— per share
Actual
-$0.27 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure